Cargando…

Second primary breast cancer after Hodgkin's disease

Although the potential carcinogenic risk of radiotherapy is well known, it has become clear that there is a particularly high risk of radiation-induced breast cancer in women treated for Hodgkin's disease at young ages. Thankfully, death from breast cancer in this population is uncommon, but it...

Descripción completa

Detalles Bibliográficos
Autores principales: Horwich, A, Swerdlow, A J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409557/
https://www.ncbi.nlm.nih.gov/pubmed/14735166
http://dx.doi.org/10.1038/sj.bjc.6601499
_version_ 1782155797123301376
author Horwich, A
Swerdlow, A J
author_facet Horwich, A
Swerdlow, A J
author_sort Horwich, A
collection PubMed
description Although the potential carcinogenic risk of radiotherapy is well known, it has become clear that there is a particularly high risk of radiation-induced breast cancer in women treated for Hodgkin's disease at young ages. Thankfully, death from breast cancer in this population is uncommon, but it is important to understand factors contributing to the risk, including treatment parameters, and to develop a logical and efficient method for medical management of those at risk. In this minireview, we examine the evidence which should inform such a management policy.
format Text
id pubmed-2409557
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24095572009-09-10 Second primary breast cancer after Hodgkin's disease Horwich, A Swerdlow, A J Br J Cancer Minireview Although the potential carcinogenic risk of radiotherapy is well known, it has become clear that there is a particularly high risk of radiation-induced breast cancer in women treated for Hodgkin's disease at young ages. Thankfully, death from breast cancer in this population is uncommon, but it is important to understand factors contributing to the risk, including treatment parameters, and to develop a logical and efficient method for medical management of those at risk. In this minireview, we examine the evidence which should inform such a management policy. Nature Publishing Group 2004-01-26 2004-01-20 /pmc/articles/PMC2409557/ /pubmed/14735166 http://dx.doi.org/10.1038/sj.bjc.6601499 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Minireview
Horwich, A
Swerdlow, A J
Second primary breast cancer after Hodgkin's disease
title Second primary breast cancer after Hodgkin's disease
title_full Second primary breast cancer after Hodgkin's disease
title_fullStr Second primary breast cancer after Hodgkin's disease
title_full_unstemmed Second primary breast cancer after Hodgkin's disease
title_short Second primary breast cancer after Hodgkin's disease
title_sort second primary breast cancer after hodgkin's disease
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409557/
https://www.ncbi.nlm.nih.gov/pubmed/14735166
http://dx.doi.org/10.1038/sj.bjc.6601499
work_keys_str_mv AT horwicha secondprimarybreastcancerafterhodgkinsdisease
AT swerdlowaj secondprimarybreastcancerafterhodgkinsdisease